Weihao
Chen‡
ac,
Jiahui
Jiang‡
b,
Xiaoyan
Pang
a,
Yingying
Song
ac,
Zhiyou
Yang
*b,
Junfeng
Wang
*acd and
Yonghong
Liu
*acd
aCAS Key Laboratory of Tropical Marine Bio-resources and Ecology/Guangdong Key Laboratory of Marine Materia Medica/Innovation Academy of South China Sea Ecology and Environmental Engineering, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, China. E-mail: wangjunfeng@scsio.ac.cn; yonghongliu@scsio.ac.cn
bCollege of Food Science and Technology, Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guangdong Provincial Engineering Technology Research Center of Seafood, Key Laboratory of Advanced Processing of Aquatic Product of Guangdong Higher Education Institution, Guangdong Ocean University, Zhanjiang 524088, China. E-mail: zyyang@gdou.edu.cn
cUniversity of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China
dSanya Institute of Marine Ecology and Engineering, Yazhou Scientific Bay, Sanya 572000, China
First published on 10th May 2024
Ten azaphilones including one pair of new epimers and three new ones, penineulones A–E (1–5) with the same structural core of angular deflectin, were obtained from a deep-sea derived Penicillium sp. SCSIO41030 fermented on a liquid medium. Their structures including absolute configurations were elucidated using chiral-phase HPLC analysis, extensive NMR spectroscopic and HRESIMS data, ECD and NMR calculations, and by comparing NMR data with literature data. Biological assays showed that the azaphilones possessed no antitumor and anti-viral (HSV-1/2) activities at concentrations of 5.0 μM and 20 μM, respectively. In addition, azaphilones 8 and 9 showed neuroprotective effects against Aβ25–35-induced neurotoxicity in primary cultured cortical neurons at a concentration of 10 μM. Azaphilones 8 and 9 dramatically promoted axonal regrowth against Aβ25–35-induced axonal atrophy. Our study indicated that azaphilones could be promising lead compounds for neuroprotection.
Pos. | 1 | 2 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
δ C type | δ H mult. (J) | δ C type | δ H mult. (J) | δ C type | δ H mult. (J) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
a Recorded in chloroform-d. b Recorded in DMSO-d6. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 | 146.2, CH | 6.91, s | 147.7, CH | 7.39, s | 145.1, CH | 7.27, s | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | 158.7, C | 158.6, C | 158.7, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | 107.5, CH | 6.01, s | 107.7, CH | 6.01, s | 104.7, CH | 6.38, s | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | 103.7, CH | 5.41, s | 103.3, CH | 5.37, s | 110.6, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | 198.3, C | 197.9, C | 190.3, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | 73.3, C | 73.2, C | 82.5, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | 45.5, CH | 3.65, d (7.7) | 45.2, CH | 3.43, d (2.7) | 43.3, CH | 3.77, d (12.0) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | 118.1, C | 116.8, C | 113.7, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | 148.6, C | 148.8, C | 139.2, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | 54.7, CH | 4.30, d (7.7) | 54.9, CH | 4.45, d (2.7) | 54.8, CH | 4.56, d (12.0) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | 207.1, C | 208.9, C | 170.1, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | 48.6, CH | 2.66, q (6.9) | 47.2, CH | 2.72, q (6.8) | 206.9, C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | 25.3, CH2 | 1.77, m | 26.0, CH2 | 1.69, m | 47.1, CH | 2.81, h (7.0) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1.39, m | 1.38, m | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | 11.4, CH3 | 0.86, t (6.5) | 11.7, CH3 | 0.84, t (6.4) | 24.0, CH2 | 1.61, m | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1.29, m | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | 19.4, CH3 | 2.14, s | 19.5, CH3 | 2.14, s | 11.5, CH3 | 0.79, t (7.4) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | 21.7, CH3 | 1.14, s | 22.4, CH3 | 1.13, s | 19.1, CH3 | 2.15, s | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | 169.4, C | 169.8, C | 9.6, CH3 | 1.72, s | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | 16.6, CH3 | 1.18, d (6.9) | 16.5, CH3 | 1.16, d (6.8) | 22.9, CH3 | 1.40, s | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | 53.0, CH3 | 3.76, s | 52.7, CH3 | 3.75, s | 15.3, CH3 | 0.92, d (7.0) |
The NMR data of compound 2 (Table 1) showed great similarity to those of 1, suggesting that they shared the same planar structure based on the same molecular formula. The remarkable distinction was the proton coupling constants between H-7 and H-10 (7.7 Hz in 1vs. 2.7 Hz in 2), indicating that they possessed different relative configurations at C-7 and C-10 (threo configuration for 1 and erythro configuration for 2).13 In addition, the optical rotation values of 1 and 2 were [α]25D +21.3 and +28.2, respectively, as well as their electronic circular dichroism (ECD) spectra were also almost the same (Fig. 3), indicating that both 1 and 2 were a pair of epimers. Considering the limited contribution of the flexible side chain to the ECD spectrum and the lack of NOESY signals of H-7 and H3-16, two truncated models a/b were used for the ECD calculations. The ECD spectrum of 6R,7S-b (Fig. 3) showed the best agreement with experimental curves, which led to the determination of the 6R,7S absolute configuration for 1 and 2. The NMR calculations of the four candidate diastereoisomers (1a/1b and 2a/2b) were then carried out using the gauge independent atomic orbital (GIAO) strategy at the B3LYP/6-31+G(d,p) level of theory with an IEFPCM solvent model of chloroform using the ORCA 5.0.3 program.14 The calculated chemical shifts of 1a/1b and 2a/2b were compared with the experimental values, respectively, applying total absolute deviation (TAD), mean absolute error (MAE), and DP4+ probability analysis as all three methods have been widely applied in addressing the stereochemical assignment of isomeric compounds.15 The lower TAD and MAE results showed that 1a and 2a are the most probable stereoisomers, and these results were further strongly supported by the DP4+ probability analysis with a high confidence level of 100% (both 1H and 13C data) (Fig. S37†). Finally, the absolute configurations of 1 and 2 were defined as (6R,7S,10S,12S) and (6R,7S,10R,12S), respectively, which confirmed that they were indeed a pair of epimers at C-10.
Compound 3 was obtained as a light-yellow oil and has the molecular formula C19H22O5 as deduced from HRESIMS data, suggesting nine degrees of unsaturation. The 1D NMR data of 3 shown in Table 1 reveal the same azaphilone skeleton with an angular lactone ring as that of the known analogue chermesinone B (8).12
The obvious differences were that the 1H NMR signal of H-4 (δH 5.34) was absent and the 13C NMR resonance of C-4 showed an upfield shift (δC 110.6 vs. 106.1), while an additional methyl signal (δC/H 9.6/1.72, s, CH3-17) was observed. Further analysis of HMBC signals from H3-17 to C-4, C-5, and C-9 (Fig. 2) indicated that the additional methyl was located at C-4. Consequently, the planar structure of 3 was established as shown. The relative configurations at C-6, C-7, C-10, and C-12 in 3 were determined by a combination of a NOESY experiment and 1H NMR coupling constant analysis. The NOESY correlations of H-10/H3-18 and H-10/H3-19 indicated that H-10, H3-18, and H3-19 were on the same side of the molecule. A large coupling constant between H-7 and H-10 (JH-7/H-10 = 12.0 Hz) and the lack of a NOE between H-7 and H3-18 revealed the trans configurations of H-7/H-10 and H-7/H3-18. Thus, considering the limited contribution of the flexible side chain to the ECD spectrum, two truncated models c and d were employed for the ECD calculations. As shown in Fig. 4A, the Boltzmann-weighted ECD spectrum of 6R,7S,10S-d showed the best agreement with the experimental curve of 3, which led to the determination of the 6R,7S,10S absolute configuration in 3. The same as for 1 and 2, NMR calculations of the two candidate diastereoisomers 3a/3b were then carried out to determine the absolute configuration at C-13 using the GIAO strategy at the B3LYP/6-31+G(d,p) level of theory with an IEFPCM solvent model of DMSO. As a result, the calculated NMR data with lower TAD and MAE values and a higher DP4+ probability of 100% (both 1H and 13C data) showed 3a to be the most probable stereoisomer (Fig. 4B). Therefore, the absolute configuration of 3 was defined as 6R,7S,10S,13S and it was named penineulone C.
![]() | ||
Fig. 4 (A) Experimental ECD spectra of 3 and calculated ECD spectra of c/d; (B) DP4+ probability, TAD, and MAE analysis of 3a/3b. |
Compound 4 was also obtained as a light-yellow oil and has the molecular formula C17H24O4 as determined from the HRESIMS ion peak at m/z 293.1675 [M + H]+ (calcd for C17H25O4, 293.1646), suggesting six degrees of unsaturation. The 1D NMR data of 4 shown in Table 2 reveal the presence of two olefinic methines CH-1 (δC/H 147.9/6.39, s) and CH-4 (δC/H 116.3/5.48, s), three sp3 methines CH-2 (δC/H 72.6/4.09, m), CH-7 (δC/H 40.9/3.00, d, J = 9.1 Hz), and CH-12 (δC/H 46.6/2.62, p, J = 6.6 Hz), three methylenes CH2-3 (δC/H 34.4/2.55, m; 2.46, m), CH2-10 (δC/H 37.7/2.86, dd, J = 18.0, 2.7 Hz; 2.76, dd, J = 18.0, 9.1 Hz) and CH2-13 (δC/H 25.5/1.59, m; 1.35, m), and four methyls at δC/H 11.3/0.79, t, J = 7.4 Hz CH3-14; 20.3/1.30, d, J = 6.2 Hz, CH3-15; 20.2/1.01, s, CH3-16 and 15.7/0.99, m, CH3-17. Besides, the signals of the remaining five tertiary carbons including two carbonyls (δC 200.8 and 212.8), two olefinics (δC 112.2 and 150.5), and one oxygenated sp3 tertiary carbon (δC 74.5) were observed in the 13C NMR spectrum. The above characteristics of the NMR data indicate the same azaphilone skeleton as that of the co-isolated known analogue chermesinone A (9).12
Pos. | 4 | 5 | ||
---|---|---|---|---|
δ C type | δ H mult. (J in Hz) | δ C type | δ H mult. (J in Hz) | |
1 | 147.9, CH | 6.39, s | 153.1, CH | 8.63, s |
2 | 72.6, CH | 4.09, m | 159.2, C | |
3 | 34.4, CH2 | 2.55, dd (13.6, 2.8) | 108.1, CH | 6.49, s |
2.46, d (13.6) | ||||
4 | 116.3, CH | 5.48, s | 103.9, CH | 5.29, s |
5 | 200.8, C | 189.5, C | ||
6 | 74.5, C | 87.4, C | ||
7 | 40.9, CH | 3.00, d (9.1) | 166.0, C | |
8 | 112.2, C | 110.5, C | ||
9 | 150.5, C | 144.5, C | ||
10 | 37.7, CH2 | 2.86, dd (18.0, 2.7) | 122.2, C | |
2.76, dd (18.0, 9.1) | ||||
11 | 212.8, C | 168.0, C | ||
12 | 46.6, CH | 2.62, p (6.6) | 199.8, C | |
13 | 25.5, CH2 | 1.59, m | 44.2, CH | 3.36, q (6.5) |
1.35, m | ||||
14 | 11.3, CH3 | 0.79, t (7.4) | 25.5, CH2 | 1.72, m |
1.29, m | ||||
15 | 20.3, CH3 | 1.30, d (6.2) | 11.6, CH3 | 0.88, t (7.4) |
16 | 20.2, CH3 | 1.01, s | 18.9, CH3 | 2.20, s |
17 | 15.7, CH3 | 0.99, m | 24.8, CH3 | 1.59, s |
18 | 15.6, CH3 | 0.93, d (7.0) |
The obvious difference between 4 and 9 was that the double bond Δ2,3 was reduced as one methine and one methylene, which was further verified by COSY correlations of H-2 and H2-3 along with the HMBC signals from H3-15 to C-2 and C-3 and from H2-3 to C-4, C-8 and C-9 (Fig. 2). Detailed analysis of the other 2D NMR signals in Fig. 2 confirmed that the planar structure of compound 4 was a reduced product of chermesinone A (9).
The absolute configuration at C-12 was determined as S, due to the same chemical shifts at CH-12 of 4 and 9 recorded in the same solvent DMSO-d6 (δC/H 46.6/2.62 for 4vs. 46.6/2.65 for 9). In addition, CH3-16 and CH2-10 were deduced to be cofacial in compound 4 through a NOESY experiment (Fig. 2), which indicated the relative configuration of 6R,7S or 6S,7R. Subsequently, the four possible diastereoisomers, (2R,6R,7S,12S)-4a, (2S,6R,7S,12S)-4b, (2R,6S,7R,12S)-4c, and (2S,6S,7R,12S)-4d, of 4 were subjected to TDDFT ECD calculations in the MeOH model. However, the calculated ECD spectra of 4a–4d were nearly the same and none of them showed the best agreement with the experimental curve (Fig. 5A). The TAD and MAE analysis of NMR calculations for the four candidate diastereoisomers (4a–4d) led to the deduction that 4 adopted the absolute configuration of (2R,6R,7S,12S)-4a with a DP4+ probability (both 1H and 13C data) of 81.11% (Fig. 5B). Therefore, the absolute configuration of 4 was defined as 2R,6R,7S,12S as shown in Fig. 1 and it was named penineulone D.
![]() | ||
Fig. 5 (A) Experimental ECD spectra of 4 and calculated ECD spectra of 4a–4d; (B) DP4+ probability, TAD, and MAE analysis of 4a–4d. |
Compound 5 was obtained as a light-yellow oil and has the molecular formula C18H18O5 as deduced from HRESIMS data, suggesting ten degrees of unsaturation. The 1D NMR data of 5 shown in Table 2 exhibit a slight difference compared with those of the co-isolated analogue 8,11-didehydrochermesinone B (6),16 which is produced by an endophytic fungus Nigrospora sp. of Aconitum carmichaeli. In the same solvent of DMSO-d6, the most obvious differences between 5 and 6 were the chemical shifts of C-12 (199.8 vs. 200.1), CH2-14 (δC/H 25.5/1.29, 1.72 vs. 25.7/1.25, 1.53), and CH3-18 (δC/H 15.6/0.93, d, J = 7.0 Hz vs. 14.5/1.05, d, J = 6.7 Hz), which enlightened us that 5 and 6 may be a pair of epimers at C-13. Similar ECD spectra of 5 and 6 indicated that they were indeed not the same compound and the calculated ECD spectra of the four candidate diastereoisomers (5a–5d) exhibited that the ECD spectra of 5 and 6 were governed mainly by the C-6 chirality center as the 6R absolute configuration (Fig. 6). Consequently, the only explanation of different chemical shifts around C-13 in 5 was that 5 was a C-13 epimer of 6, while they shared the identical 6R absolute configuration. Finally, compound 5 was determined as a new azaphilone with the 6R,13R absolute configuration and named penineulone E. To our knowledge, 5 represents the third azaphilone with an R configuration at the side chain chirality center linked to a methyl group,17,18 while most azaphilones have been discovered with an S configuration.1,2
Additionally, the other five known compounds were identified as 8,11-didehydrochermesinone B (6),16 chermesinone C (7), chermesinone B (8), chermesinone A (9),12 and anishidiol (10)19 by using X-ray diffraction crystal structures or comparison of their NMR data with those reported in the literature. The colorless crystals of 8 and 9 were obtained from a mixed solvent of CHCl3 and CH3OH (v:
v, 1
:
1). Crystallographic data for structure 8 were first reported and crystallographic data of 8 and 9 have been deposited with the Cambridge Crystallographic Data Centre under supplementary publication numbers CCDC 2214106 and 2214107† (Fig. 7).
The isolated compounds (1–10) were evaluated for their antitumor (C42B, H446, and H69 cell lines) and anti-viral (HSV-1/2) activities. However, the cell viabilities of the three human tumor cell lines were all over 80% after treatment with compounds 1–10 at a concentration of 5.0 μM for 72 h. And the CPE assay result showed no inhibition of 1–10 against HSV-1/2 at a concentration of 20 μM.
Neuroprotective effects of azaphilones against Aβ25–35-induced neurotoxicity were assessed in primary cultured cortical neurons.20 Among the ten tested compounds, 8 and 9 showed significant neuronal protective effects against Aβ25–35-induced neuronal death at a concentration of 10 μM (Fig. 8). In addition, the axonal regrowth effects of 8 and 9 were evaluated (Fig. 9A). As a result, compared with the control group, the Aβ25–35-treatment significantly reduced the length of axons in primary cultured cortical neurons. However, treatment with compounds 8 and 9 dramatically increased the length of pNF-H positive axons at both concentrations of 1 and 10 μM (Fig. 9B and C).
Penineulone A (
1
): light yellow oil; [α]25D +28.3 (c 0.1, MeOH); UV (MeOH) λmax (logε) 352 (3.88), 225 (3.76) nm; for 1H and 13C NMR data (DMSO-d6, 700/175 MHz), see Table 1; HR-ESI-MS m/z 349.1638 [M + H]+ (calcd for C19H25O6, 349.1646).
Penineulone B (
2
): light yellow oil; [α]25D +21.7 (c 0.1, MeOH); UV (MeOH) λmax (logε) 351 (3.98), 226 (3.96) nm; for 1H and 13C NMR data (DMSO-d6, 700/175 MHz), see Table 1; HR-ESI-MS m/z 349.1637 [M + H]+ (calcd for C19H25O6, 349.1649).
Penineulone C (
3
): light yellow oil; [α]25D −6.5 (c 0.1, MeOH); UV (MeOH) λmax (logε) 349 (3.75), 225 (3.58) nm; for 1H and 13C NMR (DMSO-d6, 700/175 MHz) data, see Table 1; HR-ESI-MS m/z 331.1467 [M + H]+ (calcd for C19H23O5, 331.1469).
Penineulone D (
4
): light yellow oil; [α]25D +30.1 (c 0.1, MeOH); UV (MeOH) λmax (logε) 348 (3.85), 226 (3.78) nm; for 1H and 13C NMR (DMSO-d6, 500/125 MHz) data, see Table 2; HR-ESI-MS m/z 293.1675 [M + H]+ (calcd for C17H25O4, 293.1646).
Penineulone E (
5
): light yellow oil; [α]25D −12.0 (c 0.1, MeOH); UV (MeOH) λmax (logε) 349 (3.68), 225 (3.98) nm; for 1H and 13C NMR (DMSO-d6, 500/125 MHz) data, see Table 2; HR-ESI-MS m/z 314.1167 [M + H]+ (calcd for C18H18O5, 314.1159).
In the case of conformationally flexible compounds, the conformational search was done in the gas phase using the MMFF force field. All conformers within 5 kcal mol−1 of the lowest energy conformer were subjected to further reoptimization and frequency calculations at the B3LYP/6-31G* level of theory. NMR calculations of all candidate diastereoisomers were then carried out using the gauge independent atomic orbital (GIAO) strategy at the B3LYP/6-31G*(d,p) level of theory with an IEFPCM solvent model in the ORCA 5.0.3 program.
To detect neuronal viability, primary cortical neurons were cultured for 3 days and treated with Aβ25–35 (Sigma, A4559) for 0.5 h, followed by treatment with 8 and 9 (1 and 10 μM) for 48 h. Afterwards, the cell counting kit (CCK8, APEXBIO, K1018) reagent (10 μL) was added to each well for 3 h according to the manufacturer's instructions. The absorbance values of CCK8 test were measured using a 96-well ELISA microplate reader (Biotek, VT, USA) at 450 nm. Aβ25–35 was dissolved in dH2O to a final concentration of 5 mM and was incubated at 37 °C for 4 days for aggregation.
To test the axonal regenerative effects of 8 and 9 on Aβ25–35-induced axonal atrophy, after culturing neurons for 3 days, 10 μM Aβ25–35 was pretreated for 0.5 h and then cocultured with 8 and 9 (1 and 10 μM) for 4 days. The neurons were then fixed with 4% paraformaldehyde (PFA; Solarbio, Beijing, China) at 25 °C for 1 h and immunostained for visualizing phosphorylated neurofilament H (pNF-H, 1:
500; Covance, SMI-35R, CA, United States) and microtubule-2 associated protein 2 (MAP2, 1
:
2000; Abcam, ab32454). Alexa Fluor 594-conjugated goat anti-mouse IgG (1
:
300, Abcam, ab150116) and Alexa Fluor 488-conjugated goat anti-rabbit IgG (1
:
300, Abcam, ab150081) were used as secondary antibodies. 4′,6-Diamidino-2-phenylindole (DAPI) (1 μg mL−1, Biomol, Hamburg, Germany) was used for nuclear counterstaining. A fluorescence microscope system (Echo Revolve, ECHO, CA, United States) was used for image capture at a size of 480 × 640 μm2. Ten images of each group were captured and analyzed using ImageJ (NIH), with the Neurite Tracer plugins. The average lengths of pNF-H positive axons per neuron were measured.
Footnotes |
† Electronic supplementary information (ESI) available: Copies of 1H and 13C NMR spectra of all new products, 2D NMR spectra of selected compounds, UV and MS data, and energies of all calculated conformers. CCDC 2214106 and 2214107. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d4ob00586d |
‡ These authors have contributed equally to this work. |
This journal is © The Royal Society of Chemistry 2024 |